[1]BELCHER JM, GARCIA-TSAO G, SANYAL AJ, et al.Association of AKI with mortality and complications in hospitalized patients with cirrhosis[J].Hepatology, 2013, 57 (2) :753-762.
|
[2]WONG F, O'LEARY JG, REDDY KR, et al.New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection[J].Gastroenterology, 2013, 145 (6) :1280-1288.
|
[3]BELCHER JM.Acute kidney injury in liver disease:Role of biomarkers[J].Adv Chronic Kidney Dis, 2015, 22 (5) :368-375.
|
[4]ARROYO V, FERNANDEZ J.Management of hepatorenal syndrome in patients with cirrhosis[J].Nat Rev Nephrol, 2011, 7 (9) :517-526.
|
[5]BELCHER JM, SANYAL AJ, PEIXOTO AJ, et al.Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury[J].Hepatology, 2014, 60 (2) :622-632.
|
[6]GUO DH, XU YQ.Clinical significance of urinary angiotensinogen[J].Chin J Integ Trad Western Nephrol, 2016, 17 (2) :187-188. (in Chinese) 郭冬华, 徐延琴.尿血管紧张素原的临床意义[J].中国中西医结合肾病杂志, 2016, 17 (2) :187-188.
|
[7]ZHANG XY, LYU WL, TENG J, et al.Correlation between urinary angiotensinogen and intrarenal renin-angiotensin system activity in chronic kidney disease patients[J].Chin J Nephrol, 2011, 27 (5) :327-332. (in Chinese) 章晓燕, 吕文律, 滕杰, 等.慢性肾脏病患者尿血管紧张素原与肾脏肾素血管紧张素系统活性的相关性[J].中华肾脏病杂志, 2011, 27 (5) :327-332.
|
[8]KOBORI H, OZAWA Y, SUZAKI Y, et al.Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats[J].J Am Soc Nephrol, 2005, 16 (7) :2073-2080.
|
[9]JURETZKO A, STEINBACH A, HANNEMANN A, et al.Urinary angiotensinogen and renin excretion are associated with chronic kidney disease[J].Kidney Blood Press Res, 2017, 42 (1) :145-155.
|
[10]BA AS, SANCHEZ A, BATLLE D.Angiotensinogen as a biomarker of acute kidney injury[J].Clin Kidney J, 2017, 10 (6) :759-768.
|
[11]Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association.The guideline of prevention andtreatment for chronic hepatitis B:a 2015 update[J].J Clin Hepatol, 2015, 31 (12) :1941-1960. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 (2015年更新版) [J].临床肝胆病杂志, 2015, 31 (12) :1941-1960.
|
[12]ANGELI P, GINES P, WONG F, et al.Diagnosis and management of acute kidney injury in patients with cirrhosis:revised consensus recommendations of the International Club of Ascites[J].J Hepatol, 2015, 62 (4) :968-974.
|
[13]WAGENER G, JAN M, KIM M, et al.Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery[J].Anesthesiology, 2006, 105 (3) :485-491.
|
[14]ALGE JL, KARAKALA N, NEELY BA, et al.Urinary angiotensinogen predicts adverse outcomes among acute kidney injury patients in the intensive care unit[J].Crit Care, 2013, 17 (2) :r69.
|
[15]YANG X, CHEN C, TIAN J, et al.Urinary angiotensinogen level predicts AKI in acute decompensated heart failure:A prospective, two-stage study[J].J Am Soc Nephrol, 2015, 26 (8) :2032-2041.
|
[16]LI YM, ZHOU FF, LUO Q.Research progress of non-vasomotor mechanism for cirrhosis complicated by kidney injury[J].Chin JGen Prac, 2017, 15 (8) :1407-1410. (in Chinese) 李宇玫, 周芳芳, 罗群.肝硬化并发急性肾损伤的非血管舒张机制的研究进展[J].中华全科医学, 2017, 15 (8) :1407-1410.
|
[17]TSIGOU E, PSALLIDA V, DEMPONERAS C, et al.Role of new biomarkers:Functional and structural damage[J].Crit Care Res Pract, 2013, 2013:361078.
|
[18]KASHANI K, CHEUNGPASITPORN W, RONCO C.Biomarkers of acute kidney injury:The pathway from discovery to clinical adoption[J].Clin Chem Lab Med, 2017, 55 (8) :1074-1089.
|
[19]BARRETO R, FAGUNDES C, MOREIRA R, et al.Urinary kidney injury molecule-1 (Kim-1) in the assessment of acute kidney injury in patients with cirrhosis[J].J Hepatol, 2013, 58 (3) :419.
|
[20]ROGNANT N, LEMOINE S.Evaluation of renal function in patients with cirrhosis:Where are we now?[J].World J Gastroenterol, 2014, 20 (10) :2533-2541.
|
[21] BELCHER JM, SANYAL AJ, PEIXOTO AJ, et al.Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury[J].Hepatology, 2014, 60 (2) :622-632.
|
[22]GUNGOR G, ATASEVEN H, DEMIR A, et al.Neutrophil gelatinase-associated lipocalin in prediction of mortality in patients with hepatorenal syndrome:a prospective observational study[J].Liver Int, 2014, 34 (1) :49-57.
|
[23]FAGUNDES C, PEPIN MN, GUEVARA M, et al.Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis[J].J Hepatol, 2012, 57 (2) :267-273.
|
[24]XU CH, JIANG KR.Value of serum and urinary neutrophil gelatinase-associated lipocalin and cystatin C in diagnosis of liver cirrhosis complicated by acute kidney injury[H].J Clin Hepatol, 2017, 33 (11) :2136-2140. (in Chinese) 许长红, 江坤仁.血、尿中性粒细胞明胶酶相关脂质运载蛋白与胱抑素C对肝硬化并发急性肾损伤的诊断价值[J].临床肝胆病杂志, 2017, 33 (11) :2136-2140.
|
[1] | Xiaoyong DUO, Shijie ZHANG, Hongwei ZHANG, Jing YANG, Wenqiang WANG, Linzhi YU, Baocai ZHANG, Yicheng ZHUO, Yunchao JIA, Yan PENG, Shuai HU. Association between gallstones and metabolic syndrome in southern Xinjiang, China[J]. Journal of Clinical Hepatology, 2022, 38(8): 1859-1864. doi: 10.3969/j.issn.1001-5256.2022.08.026 |
[2] | Aipire ALIYEGULI, Maimaitiyusufu PIERDIWASI, Jian WANG, Aili AIKEBAIER, Abudureyimu KELIMU. Effects of FGB gene polymorphism on fibrinogen level and gallstones incidence in Xinjiang, China[J]. Journal of Clinical Hepatology, 2021, 37(9): 2171-2176. doi: 10.3969/j.issn.1001-5256.2021.09.032 |
[3] | Peng Lu:Cheng, Shao ZhangFeng, Chen JiaQin, Chen Wei. Effect of aerobic exercise combined with silybin on intestinal mucosal barrier in mice with obstructive jaundice[J]. Journal of Clinical Hepatology, 2020, 36(7): 1577-1583. doi: 10.3969/j.issn.1001-5256.2020.07.025 |
[4] | Li ChangXu, Yuan JingJing, Wang ShouQian, Xu LuYao, Wang YingChao. Perioperative coagulation factor Ⅷ replacement therapy for patients with gallbladder stones and hemophilia A: A report of three cases[J]. Journal of Clinical Hepatology, 2020, 36(9): 2075-2076. doi: 10.3969/j.issn.1001-5256.2020.09.036 |
[5] | Zhu PeiYao, Yang Jun, Yang Yong, Han YaDong, Zhuang Lei, Han Yong. Necessity of magnetic resonance cholangiopancreatography in patients with initial diagnosis of gallstones on color Doppler ultrasound and an analysis of related indications[J]. Journal of Clinical Hepatology, 2019, 35(6): 1293-1298. doi: 10.3969/j.issn.1001-5256.2019.06.022 |
[6] | Hong Cen, Han JuQiang, Qi XingShun. An excerpt of AGA clinical practice update: Coagulation in cirrhosis (2019)[J]. Journal of Clinical Hepatology, 2019, 35(10): 2191-2191. doi: 10.3969/j.issn.1001-5256.2019.10.011 |
[7] | Xiong Zhuang, Liu YangYang, Huo ShaoKai, Gong JiaLian, Jin TianYi, Wang Qiang, Wang HuiLin, Liu TieJun, Leng Yan. Research advances in vitamin K1 in treatment of coagulopathy of liver failure[J]. Journal of Clinical Hepatology, 2019, 35(9): 2099-2103. doi: 10.3969/j.issn.1001-5256.2019.09.048 |
[8] | Li HongHong, Zhao Ge, Xue JunJun, Ning YaWen, Guo HongYi, Li WenLong, Guo ChunLei. A case of double gallbladder malformation with obstructive jaundice[J]. Journal of Clinical Hepatology, 2018, 34(7): 1535-1537. doi: 10.3969/j.issn.1001-5256.2018.07.036 |
[9] | Wang XianPeng, Meng XianZhi. Risk factors for gallstones complicated by acute biliary pancreatitis[J]. Journal of Clinical Hepatology, 2018, 34(8): 1728-1732. doi: 10.3969/j.issn.1001-5256.2018.08.027 |
[10] | Wang Bin, Luo Xiao, Sun BaoZhen, Yang Guang, Meng ZiHui, Ji DeGang. Laparoscopic cholecystectomy for cold agglutinin syndrome with gallstones: a case report[J]. Journal of Clinical Hepatology, 2017, 33(4): 740-741. doi: 10.3969/j.issn.1001-5256.2017.04.032 |
[11] | Wang Qiang, Zhang XianYong, Yan XiaoLin. Association of blood lipid levels with the risk of cholecystectomy and postoperative pain[J]. Journal of Clinical Hepatology, 2017, 33(10): 1961-1965. doi: 10.3969/j.issn.1001-5256.2017.10.022 |
[12] | Zhou BingBing, Wang XueMei, Zhang Qian, Xu ShiYi, Dan ZhongYan, Lai YaXin, Wang HaoYu. Association between metabolic syndrome and gallstones[J]. Journal of Clinical Hepatology, 2017, 33(5): 880-882. doi: 10.3969/j.issn.1001-5256.2017.05.017 |
[13] | Li Jing, Wu GuangLi, Wang Wei, Xiao Xin, Liu HuiNa, Qu DongDong, Cai YiWei. Analysis of pathogenic bacteria in bile and blood of patients with obstructive jaundice[J]. Journal of Clinical Hepatology, 2017, 33(2): 320-323. doi: 10.3969/j.issn.1001-5256.2017.02.025 |
[14] | Li Juan, Wei XiaoGuo, Lu QiMing, Zhan Li, Liu PengCheng. Research advances in association between diseases outside the gallbladder and gallstones[J]. Journal of Clinical Hepatology, 2016, 32(5): 1018-1021. doi: 10.3969/j.issn.1001-5256.2016.05.050 |
[15] | Li ZhangZheng, Liu QuanDa, Yu HuiJie, Hu WenWei, Li Xue, Liu MingHao. Correlation between serum levels of complement C5a and liver fibrosis markers in patients with obstructive jaundice[J]. Journal of Clinical Hepatology, 2016, 32(3): 495-498. doi: 10.3969/j.issn.1001-5256.2016.03.020 |
[16] | Pan YaJun, Sun ShaoFu. Predictive value of serum CA19-9 in predicting acute cholangitis in patients with obstructive jaundice[J]. Journal of Clinical Hepatology, 2016, 32(8): 1553-1556. doi: 10.3969/j.issn.1001-5256.2016.08.024 |
[17] | Lin QianHuang, Xu Hui, Tang XiaoLong, Ding Zheng, Tang WenJun, Wu KaiKai, Xun JinLiang. A case of gallstones with gallbladder-stomach fistula and biliary ileus[J]. Journal of Clinical Hepatology, 2016, 32(11): 2177-2178. doi: 10.3969/j.issn.1001-5256.2016.11.039 |
[18] | Dai ShuLong, Yang ShiYong, Yang KunXing. Systemic sclerosis with gallbladder stone disease: a report of one case[J]. Journal of Clinical Hepatology, 2015, 31(6): 963-964. doi: 10.3969/j.issn.1001-5256.2015.06.033 |
[19] | Zhang Peng, Yu CongHui. Clinical analysis of relationship between gallstone morphology and biliary pancreatitis[J]. Journal of Clinical Hepatology, 2014, 30(1): 46-49. doi: 10.3969/j.issn.1001-5256.2014.01.015 |
[20] | Wang TianRan, Wang LanTian, Qu YuanQing, Gu Yu, Zou ZiYing, Chen Li. Comparative analysis of serum markers of cardiac function in a rabbit model of and human patients with obstructive jaundice [J]. Journal of Clinical Hepatology, 2013, 29(3): 227-229. |